Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: A cross-sectional study

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  Duong, Cuong Minh ^a   Olszyna, Dariusz Piotr ^b   McLaws, Mary Louise ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

End stage renal disease; Hemodialysis; Hepatitis B virus; Hepatitis C virus; Universal precautions; Vietnam

Indexed keywords

ADOLESCENT; ADULT; AGED; BLOOD TRANSFUSION; COMORBIDITY; CROSS-SECTIONAL STUDY; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MIXED INFECTION; PROCEDURES; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; VERY ELDERLY; VIET NAM; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; CAUSALITY; COINFECTION; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK FACTORS; SURVEYS AND QUESTIONNAIRES; VIETNAM; YOUNG ADULT;

EID: 84928752519     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-1532-9     Document Type: Article

References (45)

1. Fleming GM. Renal replacement therapy review: past, present and future. Organogenesis. 2011;7:11.
2. Fresenius Medical Care, editor. ESRD patients in 2012: a global perspective. Bad Homburg: Fresenius Medical Care AG and Co. KGaA, Hof a.d. Saale; 2012.
3. WHO. Global surveillance and control of hepatitis C. J Viral Hepat. 1999;6:35-47.
4. CDC. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Recomm Rep. 1998;47:1-39.
5. Lavanchy D. The global burden of hepatitis C. Liver Int. 2009;29 Suppl 1:74-81.
6. Cendoroglo Neto M, Draibe SA, Silva AE, Ferraz ML, Granato C, Pereira CA, et al. Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant. 1995;10:240-6.
7. Hahn JA. Sex, drugs, and hepatitis C virus. J Infect Dis. 2007;195:1556-9.
8. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112-25.
9. Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology. 2010;15:137-45.
10. Bui PV. Dialysis in Vietnam. Perit Dial Int. 2007;27:400-4.
11. Approximately 6 million Vietnamese people have chronic kidney disease [in Vietnamese] [ http://www.quangninh.gov.vn/vi-vn/so/soyte/Trang/Tin%20chi%20ti%E1%BA%BFt.aspx?newsid=39anddt=2009-04-06andcid=3 ]
12. Morota K, Fujinami R, Kinukawa H, Machida T, Ohno K, Saegusa H, et al. A new sensitive and automated chemiluminescent microparticle immunoassay for quantitative determination of hepatitis C virus core antigen. J Virol Methods. 2009;157:8-14.
13. Li Cavoli G, Zagarrigo C, Schillaci O, Servillo F, Tralongo A, Coglitore M, et al. Hepatitis C virus core antigen test in monitoring of dialysis patients. Hepatitis Res Treat. 2012;2012:4.
14. Cabezas-Fernandez MT, Cabeza-Barrera MI. Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses. Open Virol J. 2012;6:122-34.
15. Tuaillon E, Mondain A-M, Nagot N, Ottomani L, Kania D, Nogue E, et al. Comparison of Serum HBsAg Quantitation by Four Immunoassays, and Relationships of HBsAg Level with HBV Replication and HBV Genotypes. PLoS One. 2012;7:e32143.
16. Nolte FS, Green AM, Fiebelkorn KR, Caliendo AM, Sturchio C, Grunwald A, et al. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5′ noncoding region. J Clin Microbiol. 2003;41:1558-64.
17. Chevaliez S, Pawlotsky JM. Hepatitis C virus: virology, diagnosis and management of antiviral therapy. World J Gastroenterol. 2007;13:2461-6.
18. Fabrizi F. Hepatitis C virus infection and dialysis: 2012 update. ISRN Nephrol. 2013;2013:11.
19. Pham TD. Current donated blood screening status of some blood-borne pathogens. [in Vietnamese]. In: Orientation on viral hepatitis prevention and control in Vietnam. Hanoi: Vietnam Ministry of Health; 2012.
20. Do NP. Decision on promulgation of the hospital regulation. [in Vietnamese]. Hanoi: Vietnam Ministry of Health; 1997.
21. Phan BL, Tran VB, Pham HP. The problem of HCV infection at Cho Ray hospital [in Vietnamese]. Tap Chi Y Hoc Viet Nam. 1995;9:27-31.
22. Bui TMA, Do TP, Nguyen YL, Nguyen TV, Nguyen CT, Do MT, et al. HCV infection among haemodialysis patients and some subjects who have relationship with blood transfusion in Vietnam [in Vietnamese]. Tap Chi Y Hoc Viet Nam. 1999;1:13-8.
23. Do TP. Result of the national HIV, HCV, HBV screening program for the blood donors from 1996 to 2000 [in Vietnamese]. Tap Chi Y Hoc Viet Nam. 2001;12:5-8.
24. Dunford L, Carr MJ, Dean J, Waters A, Nguyen LT, Ta Thi TH, et al. Hepatitis C virus in Vietnam: high prevalence of infection in dialysis and multi-transfused patients involving diverse and novel virus variants. PLoS One. 2012;7:e41266.
25. Nguyen B, Nguyen VT, Bui VT, Le NT, Bui TH, Tran HND. Epidemiology of hepatitis B and C virus infection in chronic hemodialysis: a study during 6 years. [in Vietnamese]. Y Hoc Thanh Pho Ho Chi Minh. 2012;16:77-83.
26. El-Sherif A, Elbahrawy A, Aboelfotoh A, Abdelkarim M, Saied Mohammad AG, Abdallah AM, et al. High false-negative rate of anti-HCV among Egyptian patients on regular hemodialysis. Hemodial Int. 2012;16:420-7.
27. Hou J, Liu Z, Gu F. Epidemiology and Prevention of Hepatitis B Virus Infection. Int J Med Sci. 2005;2:50-7.
28. Nguyen VTT, Law MG, Dore GJ. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int. 2008;28:525-31.
29. Nguyen VT, McLaws ML, Dore GJ. Highly endemic hepatitis B infection in rural Vietnam. J Gastroenterol Hepatol. 2007;22:2093-100.
30. Marwaha N, Sachdev S. Current testing strategies for hepatitis C virus infection in blood donors and the way forward. World J Gastroenterol. 2014;20:2948-54.
31. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, et al. International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang. 2012;102:82-90.
32. Nguyen TX. Circular of information for the blood transfusion activities [decision, in Vietnamese]. Hanoi: Vietnam Ministry of Health; 2013.
33. Macdougall IC, Obrador GT. How important is transfusion avoidance in 2013? Nephrol Dial Transplant. 2013;28:1092-9.
34. Fissell RB, Bragg-Gresham JL, Woods JD, Jadoul M, Gillespie B, Hedderwick SA, et al. Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. Kidney Int. 2004;65:2335-42.
35. Savey A, Simon F, Izopet J, Lepoutre A, Fabry J, Desenclos JC. A large nosocomial outbreak of hepatitis C virus infections at a hemodialysis center. Infect Control Hosp Epidemiol. 2005;26:752-60.
36. Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, et al. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: a ten years of surveillance. Mem Inst Oswaldo Cruz. 2005;100:345-9.
37. Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis. 2010;14:1-21.
38. Chao DT, Abe K, Nguyen MH. Systematic review: epidemiology of hepatitis C genotype 6 and its management. Aliment Pharmacol Ther. 2011;34:286-96.
39. Ho TD, Pham TTT, Nguyen TT, Nguyen BT, Phan HBH, Nguyen BT, et al. Prevalence of HCV genotypes in Vietnam [in Vietnamese]. Y Hoc Thanh Pho Ho Chi Minh. 2006;10:28-34.
40. Nguyen TB, Pham HV. Apply the direct sequencing of the QPCR products [in Vietnamese]. Y Hoc Thanh Pho Ho Chi Minh. 2009;13:243-8.
41. Truong TP. Characteristics of HCV infection among haemodialysis patients at Bach Mai hospital [Master dissertation, in Vietnamese]. Hanoi: Hanoi Medical University, Microbiology Department; 2008.
42. Bui HH, Dinh DLH, Pham HP, Sablon E. Hepatitis B genotypes in patients with cirrhosis and hepatocellular carcinoma [in Vietnamese]. Y Hoc Thanh Pho Ho Chi Minh. 2003;7:128-33.
43. Dang MAT, Vo DXA, Pham HV. Surveillance of the mutations responsible for Adefovir and Lamivudine resistance on the HBV extracted from patients' sera with chronic hepatitis B. [in Vietnamese]. Y Hoc Thanh Pho Ho Chi Minh. 2010;14:287-93.
44. Jasuja S, Gupta AK, Choudhry R, Kher V, Aggarwal DK, Mishra A, et al. Prevalence and associations of hepatitis C viremia in hemodialysis patients at a tertiary care hospital. Indian J Nephrol. 2009;19:62-7.
45. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, et al. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology. 1995;109:1295-300.